相关实验视频

Updated: Sep 9, 2025

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.2K

一个无细胞DNA等离子体下一代测序测试 - - 值得花费吗?

Sean Jung1,2, Francesca Torriani1,2, Shira Abeles1,2

  • 1Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA 92093, USA.

Pathogens (Basel, Switzerland)
|August 28, 2025
PubMed
概括

在大多数情况下,Karius测试 (KT) 的临床益处有限,尽管它有助于特定的感染. 建议进行诊断管理,以优化其使用和管理成本.

关键词:
卡里乌斯测试没有细胞的DNA临床效用经济效益传染病诊断下一代测序管理工作

更多相关视频

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

4.1K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K

相关概念视频

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
92.6K